Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease have?
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease has 808 citations in the OpenAlex counts ScholarIQ stores.
When was Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease published?
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease has 2017 year in the ScholarIQ index.
What is the open-access status of Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease?
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease has bronze oa status in the ScholarIQ index.
What is the DOI of Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease?
The DOI for Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease is on the source record.
What is the PMID of Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease?
The PMID for Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease is on the source record.
What is the OpenAlex record for Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease?
The OpenAlex for Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease is on the source record.